[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.92.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Lab Reports
April 6, 2011

PTSD Enzyme

JAMA. 2011;305(13):1290. doi:10.1001/jama.2011.388

An enzyme called pituitary adenylate cyclase–activating polypeptide (PACAP) may play a role in posttraumatic stress disorder (PTSD) in women but not men, according to new research from the Emory University School of Medicine in Atlanta, the University of Vermont in Burlington, and other institutions (Ressler KJ et al. Nature. 2011;470[7335]:492-497).

PACAP and its receptor (PAC1) are known to regulate the response of cells to stress. To assess whether these proteins are associated with PTSD, investigators analyzed blood levels of PACAP as well as variation and modification of the genes encoding PACAP and PAC1 in a cohort of more than 1200 highly traumatized individuals with and without PTSD.

First Page Preview View Large
First page PDF preview
First page PDF preview
×